Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
35.9M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
20.3M
-
Shares change
-
+545K
-
Total reported value, excl. options
-
$76.2M
-
Value change
-
+$1.66M
-
Number of buys
-
28
-
Number of sells
-
-30
-
Price
-
$3.76
Significant Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q1 2025
78 filings reported holding BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share as of Q1 2025.
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.3M shares
of 35.9M outstanding shares and own 56.53% of the company stock.
Largest 10 shareholders include AH CAPITAL MANAGEMENT, L.L.C. (3.23M shares), Cormorant Asset Management, LP (2.63M shares), Sofinnova Investments, Inc. (2.3M shares), TANG CAPITAL MANAGEMENT LLC (1.6M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.45M shares), RA CAPITAL MANAGEMENT, L.P. (1.05M shares), ADAR1 Capital Management, LLC (971K shares), ORBIMED ADVISORS LLC (922K shares), RTW INVESTMENTS, LP (786K shares), and Sands Capital Ventures, LLC (786K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.